Delighted to launch this programme which enables @nanopore to continue improving genomics sequencing workflows for our end users via close collaboration with our partners. #NanoporeCommunity 📣
Excited to announce the launch of the Compatible Products Programme.
The new initiative is designed to expand the network of approved third-party products to foster a more accessible genomics ecosystem & new applications of nanopore technology.
Read: https://t.co/BWqEwUhjH3
Today we announce that GridION™ Dx is now CE and UKCA marked — our first IVD registered in the UK & Europe. This milestone confirms compliance with rigorous quality, safety & performance standards, supporting future clinical adoption.
Learn more: https://t.co/9NhgAM0r0b
In-person tickets for London Calling 2025 are now sold out! If you missed this opportunity — the waitlist is still open for those hoping to join us in person.
Prefer to tune in from anywhere? Free online tickets are still available.
Learn more: https://t.co/icXPcSm7HF
Today we announce the expansion of our Compatible Products Programme, welcoming a new cohort of leading partners whose products now integrate seamlessly with Oxford Nanopore technology - reinforcing our commitment to building an open, collaborative system. https://t.co/AZJbmWRzCR
We have collaborated with @CariGenetics to support the first large-scale genomic sequencing initiative in the Caribbean. This pioneering effort is set to address critical health disparities in the region by providing real-time, high-throughput sequencing. https://t.co/GtxXbenfA7
We are partnering with @Pathosense to bring a rapid, comprehensive, sequencing-based diagnostic solution for livestock and pets — empowering veterinarians with deeper insights to make informed treatment decisions.
Read more: https://t.co/SF41LIugCJ
.@nanopore CEO Looks Beyond Native DNA, RNA Sequencing
“I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics...
https://t.co/aJ2cqaHoqN
Introducing... the MinION Mk1D.
Learn how — from research labs to the Arctic tundra — the real-time portable sequencer lowers the barrier to accessing genomic information, enabling novel insights anywhere, by anyone.
Learn more: https://t.co/uCOkWGORPt
Proud to partner with UK Government, @GenomicsEngland, @uk_biobank, & @NHSEngland to drive genomics-based healthcare in the UK! This initiative supports breakthroughs in patient care, biomedical research, and pandemic preparedness.
Read more here: https://t.co/n5iHt0Vfi8
With the launch of M4 Max / Pro today we see a “tremendous performance boost for the 14” / 16” MacBook Pro making it the ideal choice for researchers” @trevormcleod@nanopore#AppleEvent
https://t.co/FLWcgCX7h4
I am looking forward to giving a talk at @EarlhamInst for #EIInnovate 2024. I'll be discussing how our collaboration between @nanopore and @EarlhamInst has been transformative in delivering impact, with a specific focus on mod bases. #newmodmodel
https://t.co/tSirJD2L9a
BugSeq is delighted to announce that we are now listed on the @nanopore compatible products page. This listing provides users with enhanced confidence in the performance of BugSeq’s analysis platform with ONT sequencing workflows.
Published today in @Nature, we describe an approach for single-molecule protein reading on @nanopore arrays. By utilizing ClpX unfoldase to ratchet proteins through a CsgG nanopore, we achieved single-amino-acid sensitivity. https://t.co/ZTFNZkwpcj
Excited to announce a new collaboration led by led by Precision Health Research, Singapore (PRECISE). They'll sequence 10,000 genomes using nanopore technology to better understand the genetic diversity of Singapore's multi-ethnic population.
Learn more: https://t.co/ZT9bskpQOq
Introducing NO-MISS: An end-to-end method for rapid, comprehensive isolate sequencing. Flexible sample batching & cost efficiency make it ideal for detecting outbreaks, understanding microbial evolution, food safety, & clinical research.
Learn more: https://t.co/V3Lj83N6P2